ORGANIC
LETTERS
2007
Vol. 9, No. 3
461-463
Total Synthesis of (±)-Hedychilactone
B: Stepwise Allenoate Diene
Cycloaddition To Prepare
Trimethyldecalin Systems
Michael E. Jung* and Masayuki Murakami
Department of Chemistry and Biochemistry, UniVersity of California, Los Angeles,
405 Hilgard AVenue, Los Angeles, California 90095
Received November 18, 2006
ABSTRACT
The total synthesis of the diterpene hedychilactone B 1 is reported. The exo adduct 4x, the major product of the stepwise [4
of the diene 2 and the allenoate 3, has been converted into 1 via 7 steps, among them a key nonconjugative hydrolysis of a
enol ether and an E-selective olefination.
+
γ
2] cycloaddition
-methylene silyl
Hedychilactone B 1 (Scheme 1), a labdane diterpene isolated
from various types of Zingiberaceae plants, e.g., Hedychium
literature to date. Recently we reported the preparation of
very hindered trimethyldecalin systems, involving a novel
stepwise [4+2] cycloaddition of the very hindered diene 2
with the allene carboxylate 3 to give the [4+2] cycloadducts
4xn by a mechanism that proceeds via the cyclobutane 5,
the initial [2+2] cycloadduct.2 We report here the total
synthesis of hedychilactone B 1 from the exo [4+2]
cycloadduct 4x via a key nonconjugative hydrolysis of a
γ-methylene silyl enol ether and an E-selective olefination
to install the desired E-alkylidene lactone.
Scheme 1
As we reported earlier, the trimethylcyclohexenyl diene 2
was prepared from 2,6-dimethylcyclohexanone in six steps
and 51% overall yield: methylation, Barton vinyl iodide
formation3 (via the corresponding hydrazone), trapping of
coronarium Koen, has anti-inflammatory activity and has
shown strong inhibition of nitric oxide production (IC50 28
µM).1 No synthesis of this lactone has appeared in the
(2) Jung, M. E.; Murakami, M. Org. Lett. 2006, 8, 5857-5859.
(3) (a) Barton, D. H. R.; Bashiardes, G.; Fourrey, J. L. Tetrahedron Lett.
1983, 24, 1605-1608. (b) Kende, A. S.; Deng, W.-P.; Zhong, M.; Guo,
X.-C. Org. Lett. 2003, 5, 1785-1788. (c) Di Grandi, M. J.; Jung, D. K.;
Krol, W. J.; Danishefsky, S. J. J. Org. Chem. 1993, 58, 4989-4992. (d)
Pazos, Y.; Iglesias, B.; de Lera, A. R. J. Org. Chem. 2001, 66, 8483-
8489. (e) Helliwell, M.; Thomas, E. J.; Townsend, L. A. J. Chem. Soc.,
Perkin Trans. 1 2002, 1286-1296. (f) Jung, M. E.; Duclos, B. A.
Tetrahedron 2006, 62, 9321-9334.
(1) (a) Morikawa, T.; Matsuda, H.; Sakamoto, Y.; Ueda, K.; Yoshikawa,
M. Chem. Pharm. Bull. 2002, 50, 1045-1049. (b) Matsuda, H.; Morikawa,
T.; Sakamoto, Y.; Toguchida, I.; Yoshikawa, M. Bioorg. Med. Chem. 2002,
10, 2527-2534. (c) Matsuda, H.; Morikawa, T.; Sakamoto, Y.; Toguchida,
I.; Yoshikawa, M. Heterocycles 2002, 56, 45-50.
10.1021/ol062811z CCC: $37.00
© 2007 American Chemical Society
Published on Web 01/12/2007